Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A, Haematology BS (2017) The diagnosis and management of primary autoimmune haemolytic anaemia. Br J Haematol 176:395–411

Article  PubMed  Google Scholar 

Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E, Lunghi M, Tassinari C, Alfinito F, Ferrari A (2014) Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood J Am Soc Hematol 124:2930–2936

CAS  Google Scholar 

Go RS, Winters JL, Kay NE (2017) How I treat autoimmune hemolytic anemia. Blood J Am Soc Hematol 129:2971–2979

CAS  Google Scholar 

Sallah S, Sigounas G, Vos P, Wan J, Nguyen N (2000) Autoimmune hemolytic anemia in patients with Non-hodgkin’s lymphoma: characteristics and significance. Ann Oncol 11:1571–1577

Article  CAS  PubMed  Google Scholar 

Sallah S, Wan JY, Hanrahan LR (2001) Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clin Cancer Res 7:791–794

CAS  PubMed  Google Scholar 

Bauduer F (2001) Correspondence: Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low‐grade non‐Hodgkin’s lymphoma. Br J Haematol 112:1085–1086

CAS  PubMed  Google Scholar 

Jiang M, Bennani NN, Feldman AL (2017) Lymphoma classification update: B-cell non-hodgkin lymphomas. Expert Rev Hematol 10:405–415

Article  CAS  PubMed  Google Scholar 

Jiang M, Bennani NN, Feldman AL (2017) Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms. Expert Rev Hematol 10:239–249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen M, Vistarop AG, Huaman F, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA (2018) Epstein-Barr virus lytic cycle involvement in diffuse large B cell lymphoma. Hematol Oncol 36:98–103

Article  CAS  PubMed  Google Scholar 

Jachiet V, Mekinian A, Carrat F, Grignano E, Retbi A, Boffa J-J, Ronco P, Rondeau E, Sellam J, Berenbaum F (2018) Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study. Leuk Lymphoma 59:1399–1405

Article  PubMed  Google Scholar 

Seve P, Philippe P, Dufour J-F, Broussolle C, Michel M (2008) Autoimmune hemolytic anemia: classification and therapeutic approaches. Expert Rev Hematol 1:189–204

Article  CAS  PubMed  Google Scholar 

Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, Nagata Y, Shiraishi Y, Chiba K, Tanaka H (2019) Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. Leukemia 33:2867–2883

Article  CAS  PubMed  Google Scholar 

Maura F, Dodero A, Carniti C, Bolli N, Magni M, Monti V, Cabras A, Leongamornlert D, Abascal F, Diamond B (2021) CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). Haematologica 106:2918

Article  CAS  PubMed  Google Scholar 

Zhu F, Li Q, Pan H, Xiao Y, Liu T, Liu X, Li J, Wu G, Zhang L (2020) Successful treatment of Chidamide and Cyclosporine for Refractory/Relapsed Angioimmunoblastic T Cell Lymphoma with Evans Syndrome: a Case Report with Long-Term Follow-Up. Front Oncol 10:558677

Google Scholar 

Delfau-Larue M-H, de Leval L, Joly B, Plonquet A, Challine D, Parrens M, Delmer A, Salles G, Morschhauser F, Delarue R (2012) Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. haematologica 97:1594

Shi Y, Dong M, Hong X, Zhang W, Feng J, Zhu J, Yu L, Ke X, Huang H, Shen Z (2015) Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol 26:1766–1771

Article  CAS  PubMed  Google Scholar 

Crickx E, Poullot E, Moulis G, Goulabchand R, Fieschi C, Galicier L, Meignin V, Coppo P, Delarue R, Casasnovas O (2019) Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma. Eur J Haematol 103:35–42

Article  CAS  PubMed  Google Scholar